Demonstrate Your Commitment to Patient Safety:
Adopt ISMP's 2016-2017 Best Practices
Wednesday, February 24, 2016 - 1:30pm-3:00pm ET
Join ISMP for a FREE webinar that will discuss the newly released 2016-2017 Targeted Medication Safety Best Practices for Hospitals. ISMP is urging the widespread, national adoption of these consensus-based best practices, which are designed to help eliminate ongoing medication safety issues that continue to cause fatal and harmful errors in patients. The webinar will discuss five new practices that have been added, and provide examples of the medication errors that med to their selection.
Participants will hear an overview of the new best practices, addressing safe storage and availability of critical medications, including neuromuscular blocking agents, antidotes and reversal agents, as well as 1,000 mL bags of sterile water. In particular, learn about ISMP's recommendation to adopt the widespread use of smart pumps with error-reduction software for high-alert infusions, and a reliable process for independent verification of ingredients when compounding sterile preparations. Important revisions to two of the earlier best practices that remain active this year will be highlighted.
Our speaker also will provide an updated on the national progress with implementation of ISMP's 2014-2015 Targeted Medication Safety Best Practices, and give participants the opportunity to weigh in on current adoption. Don't miss this opportunity- sign up today.
The target audience for this activity includes hospital leadership, medical staff leadership in hospitals, risk and quality managers, patient and medication safety officers/specialists, hospital pharmacy management, hospital pharmacists and pharmacy technicians, nurse administrators, nurse managers, educators, and frontline staff, respiratory care staff, staff from diagnostic care areas who administer medications.
At the completion of this symposium, the participant should be able to:
- Cite the three most implemented, and three least implemented best practices from the 2014-2015 ISMP Targeted Medication Best Practices for Hospitals.
- Describe two revisions each to best practices 2 and 3 for 2016-2017, along with the reason for the revisions.
- List the five new best practices for 2016-2017 and the medication errors that each of these new practices were designed to prevent.
Michael R. Cohen, MS, ScD (hon), FASHP
Institute for Safe Medication Practices
Darryl S. Rich, PharmD, MBA, FASHP
Medication Safety Specialist
Institute for Safe Medication Practices
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-035-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date February 24, 2016). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than March 25, 2016 is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.
This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.5 contact hour of nurse CE credit.
Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Faculty disclosures will be announced at the beginning of the CE activity.
Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgement in applying the presented information in patient-care activities.
This activity is funded through an educational grant from Novartis Pharmaceutical Corporation.
-Computer with broadcast Internet access
-Soundcard and speakers or headphones for your computer (or dial-in via telephone for audio)
After registering you will receive a confirmation email containing information about joining the Webinar.
TO REGISTER: COPY and PASTE THIS LINK: